In MVOR-1, 65% of patients treated with Emrosi achieved IGA success at week 16 compared with 46% of the doxycycline group (treatment difference, 18% [95% CI, 5-31]) and 31% of the placebo group ...
Some results have been hidden because they may be inaccessible to you